Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer

References

Page 1

	Year	Citations
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer Joan H. Schiller, David Harrington, Chandra P. Belani, New England Journal of Medicine	2002	4.9K
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Science	2007	4.4K
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER J Oan H. S Chiller, D Avid H Arrington, C Handra P. B Elani, Median SurvivalMedicineCancer ManagementPharmacologyToreceive Cisplatin	2002	3.7K
Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB" Sankar Ghosh, David Baltimore Nature InflammationCytokineInhibitor IκbSignal TransductionSignaling Pathway	1990	1.2K
Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life M.H. Cullen, Lucinda Billingham, C.M. Woodroffe, Journal of Clinical Oncology	1999	448
Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer Manuel Cobo, Dolores Isla, Bartomeu Massutí, Journal of Clinical Oncology	2007	442
Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide Nikhil Patel, Shinichi Nozaki, Nicholas H. Shortle, Oncogene Paclitaxel SensitivityBreast OncologyActive Nf-κbMedicineBreast Cancer Cells	2000	294
Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy Jeong‐Seon Ryu, Yun‐Chul Hong, Hye Seung Han, Lung Cancer MedicinePathologyCancer GenomicsBronchial NeoplasmCancer Treatment	2004	221
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life Stephen Spiro Thorax	2004	209
Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer Kapil Mehta, Jansina Y. Fok, Fred R. Miller, Clinical Cancer Research	2004	184

Page 1